PTPRO and breast carcinoma: Next, we analyzed two public available datasets GSE38376 (Komurov et al., 2012) and GSE16179 (Liu et al., 2009) and found that the PTPRO mRNA level is lower in lapatinib-resistant breast cancer cells (SKBR3-lapR and BT474-lapR) than that of their parental cells (SKBR3-P and BT474-P) (Figure 3A).